Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Reasons behind variation in NSTEMI bleeding rates unclear

The rate of in-hospital major bleeding events among non-ST-segment elevation myocardial infarction (NSTEMI) patients varies considerably between facilities, researchers found in a study published online March 4 in Circulation: Cardiovascular Quality and Outcomes, but the reasons behind the majority of cases remain unclear.

Thumbnail

Transradial PCI may lower risk of acute kidney injury

To prevent acute kidney injury (AKI) in patients undergoing PCI, physicians may want to select a transradial approach rather than a transfemoral approach. A study published online Feb. 25 in Circulation: Cardiovascular Interventions found an association between radial PCI and a lower risk of AKI compared with the femoral approach.

OrbusNeich initiates HARMONEE study in Japan to evaluate the COMBO(tm) dual therapy stent

OrbusNeich today announced that patient enrollment has been initiated in Japan in the pivotal clinical trial of the COMBO Dual Therapy Stent(tm) (COMBO Stent) employing a single Japan-U.S. protocol conducted as a Global Clinical Trial "proof-of-concept" under the framework of the joint Japan-U.S. Harmonization-By-Doing [HBD] initiative. The first patient was enrolled at Shonan Kamakura General Hospital, Japan, by Dr. Shigeru Saito, M.D., the vice director of the hospital and co-principal investigator of the study.

Calcification may lead to poor prognosis after NSTEACS and STEMI

Moderate or severe coronary calcification is common in patients with non-ST elevated acute coronary syndrome (NSTEACS) and STEMI, according to a study published online Feb. 19 in the Journal of the American College of Cardiology. The study also found the degree of calcification predictive of stent thrombosis and ischemic target lesion revascularization.

FDA recalls guidewires used in cath procedures

The FDA is recalling guidewires used in catheter procedures because the coating may flake off. The agency warned that use of the guidewire could have serious adverse consequences.

High-potency statins may lower mortality risk after heart attacks

High-potency statin use in patients who had heart attacks may lower mortality risk compared with simvastatin monotherapy, according to a study published online Feb. 19 in Heart.

Morphine may diminish clopidogrel’s effect

Using morphine along with clopidogrel may adversely affect the action of clopidogrel, potentially leading to treatment failure, according to a study published in the Feb. 25 issue of the Journal of the American College of Cardiology.

Robotic-assisted coronary angioplasty procedures will be highlighted during CRT2014 conference in Washington, D.C.

Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced that in addition to a talk focusing on robotics in the future of the cath lab, cases submitted by users of its CorPath Vascular Robotics System have been accepted for presentation at the Cardiovascular Research Technologies (CRT) conference on February 22 – 25, 2014 in Washington, D.C.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.